Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RALOXIFEN ARENA 60 mg
Selective oestrogen receptor modulator, indicated in the prevention and treatment of postmenopausal osteoporosis
Active Substance (INN)
RALOXIFENUM HYDROCHLORIDUM
Packaging
1,2,6 blisters x 10 FCT
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.